StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Filana Therapeutics's pe ratio was 4.0× on Jan 30, 2015.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Jan 30, 20154.0×−0.1
2014Dec 31, 20144.1×–

More Filana Therapeutics figures

See a number that looks wrong?